1. Home
  2. DTCK vs UBX Comparison

DTCK vs UBX Comparison

Compare DTCK & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTCK
  • UBX
  • Stock Information
  • Founded
  • DTCK 1999
  • UBX 2009
  • Country
  • DTCK Singapore
  • UBX United States
  • Employees
  • DTCK N/A
  • UBX N/A
  • Industry
  • DTCK Farming/Seeds/Milling
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DTCK Industrials
  • UBX Health Care
  • Exchange
  • DTCK Nasdaq
  • UBX Nasdaq
  • Market Cap
  • DTCK 26.5M
  • UBX 24.6M
  • IPO Year
  • DTCK 2023
  • UBX 2018
  • Fundamental
  • Price
  • DTCK $0.99
  • UBX $0.96
  • Analyst Decision
  • DTCK
  • UBX Strong Buy
  • Analyst Count
  • DTCK 0
  • UBX 1
  • Target Price
  • DTCK N/A
  • UBX $8.00
  • AVG Volume (30 Days)
  • DTCK 595.7K
  • UBX 93.3K
  • Earning Date
  • DTCK 11-13-2024
  • UBX 11-04-2024
  • Dividend Yield
  • DTCK N/A
  • UBX N/A
  • EPS Growth
  • DTCK N/A
  • UBX N/A
  • EPS
  • DTCK 0.02
  • UBX N/A
  • Revenue
  • DTCK $159,836,000.00
  • UBX N/A
  • Revenue This Year
  • DTCK N/A
  • UBX N/A
  • Revenue Next Year
  • DTCK N/A
  • UBX $33.62
  • P/E Ratio
  • DTCK $51.82
  • UBX N/A
  • Revenue Growth
  • DTCK N/A
  • UBX N/A
  • 52 Week Low
  • DTCK $0.76
  • UBX $0.95
  • 52 Week High
  • DTCK $1.75
  • UBX $2.02
  • Technical
  • Relative Strength Index (RSI)
  • DTCK 48.91
  • UBX 26.17
  • Support Level
  • DTCK $0.95
  • UBX $1.10
  • Resistance Level
  • DTCK $1.11
  • UBX $1.23
  • Average True Range (ATR)
  • DTCK 0.12
  • UBX 0.07
  • MACD
  • DTCK 0.01
  • UBX -0.02
  • Stochastic Oscillator
  • DTCK 26.40
  • UBX 4.46

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: